香港股市 已收市

Ajanta Pharma Limited (AJANTPHARM.NS)

NSE - NSE 即時價格。貨幣為 INR。
加入追蹤清單
2,287.20+3.45 (+0.15%)
收市:03:29PM IST

Ajanta Pharma Limited

Ajanta House
98 Govt. Industrial Area Charkop Kandivili (West)
Mumbai 400067
India
91 22 6606 1000
https://www.ajantapharma.com

版塊Healthcare
行業Drug Manufacturers - Specialty & Generic
全職員工8,073

高階主管

名稱頭銜支付行使價出生年份
Mr. Yogesh Mannalal Agrawal M.B.AMD & Executive Director215.96M1972
Mr. Rajesh Mannalal Agrawal M.B.AJoint MD & Director215.96M1976
Mr. Madhusudan Bhagwandas Agrawal B.ScExecutive Vice Chairman of the Board42.04M1955
Mr. Arvind K. Agrawal B Com, F.C.A, L.L.BChief Financial Officer1963
Mr. Gaurang Chinubhai ShahSenior VP of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer
Mr. H. Satish Agrawal M PharmPresident of Tech & Operations1963
Mr. Thampy JacobSenior Vice President of HR
Mr. H. Nandkishore AgrawalPresident of International Business1960
Mr. Pankaj BarbindDeputy General Manager of Sustainability
Mr. Jagdish Dwarkadas JoshiExecutive Vice President
截止 2024年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 INR。

描述

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets speciality pharmaceutical finished dosages. The company markets and serves various therapeutic segments, such as cardiology, antidiabetic, ophthalmology, dermatology, pain management, and respiratory areas. It also provides tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company serves in India, Africa, rest of Asia, the United States, and internationally. Ajanta Pharma Limited was founded in 1973 and is headquartered in Mumbai, India.

公司管治

截至 無 止,Ajanta Pharma Limited 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。